K. Levina

Discordant Resistance to Kanamycin and Amikacin in Drug-Resistant Mycobacterium tuberculosis

P. Juréen, S. Hoffner, S. Ghebremichael, 2003, Antimicrobial Agents and Chemotherapy.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

E. Kurbatova, M. L. van der Walt, C. Kvasnovsky, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis.

S. Lockman, N. Binkin, J. Tappero, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid Assay for Detection of the Epidemiologically Important Central Asian/Russian Strain of the Mycobacterium tuberculosis Beijing Genotype

P. Suffys, N. Solovieva, E. Chernyaeva, 2017, Journal of Clinical Microbiology.

Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority country.

I. Mokrousov, K. Levina, P. Viiklepp, 2020, Transboundary and emerging diseases.

Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context

I. Mokrousov, K. Levina, P. Viiklepp, 2018, The Journal of antimicrobial chemotherapy.

Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia

S. Svenson, S. Hoffner, S. Ghebremichael, 2001, Journal of Clinical Microbiology.

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

V. Leimane, D. Manissero, L. Geiter, 2012, European Respiratory Journal.

Drug resistant tuberculosis in Estonia.

S. Svenson, S. Hoffner, G. Källenius, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster

I. Mokrousov, K. Levina, A. Vyazovaya, 2020 .

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Carmen Z. Suarez, E. Kurbatova, M. L. van der Walt, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Carmen Z. Suarez, E. Kurbatova, M. L. van der Walt, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.